ライフサイエンスコーパス: luteinize

1 ic releasing hormones from the hypothalamus, luteinizing and follicle stimulating hormones from the p

2 In this report we established, using luteinized granulosa cells, that PGF(2alpha) stimulates

3 ol <184 pmol/l (50 pg/ml), FSH <10 IU/l, and luteinizing hormone <10 IU/l, was significantly more pre

4 , and lower follicle-stimulating hormone and luteinizing hormone (each P < .01).

5 Human luteinizing hormone (hLH) and human chorionic gonadotrop

6 he number of days from the midcycle surge in luteinizing hormone (LH) (P=.008).

7 s thought to be indirectly controlled by the luteinizing hormone (LH) acting through the LH/choriogon

8 Meiosis in mammalian oocytes is paused until luteinizing hormone (LH) activates receptors in the mura

9 Luteinizing hormone (LH) acts on ovarian follicles to re

10 The signaling pathway by which luteinizing hormone (LH) acts on the somatic cells of ve

11 with consequent diminished levels of plasma luteinizing hormone (LH) and correspondingly attenuated

12 esis and secretion of gonadotropic hormones, luteinizing hormone (LH) and follicle stimulating hormon

13 osynthesis and release of the gonadotropins, luteinizing hormone (LH) and follicle stimulating hormon

14 Luteinizing hormone (LH) and follicle-stimulating hormon

15 ith gonadotropic endocrine cells [expressing luteinizing hormone (LH) and follicle-stimulating hormon

16 close to follicle-stimulating hormone (FSH), luteinizing hormone (LH) and growth hormone (GH) cells.

17 ssociation between serum levels of wild-type luteinizing hormone (LH) and ovarian cancer risk.

18 In GnRH-CREB KO mice, basal levels of luteinizing hormone (LH) and the postovariectomy increme

19 of gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) are pivotal events in female re

20 FSH and luteinizing hormone (LH) are secreted constitutively or

21 oma cells were treated with the gonadotropin luteinizing hormone (LH) at concentrations equivalent to

22 The half-life for luteinizing hormone (LH) clearance increases in Mrc1(-/-

23 serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) clearly separated hypogonadotro

24 validate AutoDecon for application to serum luteinizing hormone (LH) concentration time series using

25 A surge of luteinizing hormone (LH) from the pituitary gland trigge

26 (GNRH)-stimulated synthesis and secretion of luteinizing hormone (LH) from the pituitary gonadotroph.

27 ating follicle-stimulating hormone (FSH) and luteinizing hormone (LH) gene expression in the pituitar

28 inhibited the kisspeptin-induced release of luteinizing hormone (LH) in rats and mice and blocked th

29 or tissue remodeling process is triggered by luteinizing hormone (LH) in the ovarian follicle.

30 and then augments (positive feedback) serum luteinizing hormone (LH) increased Kiss1 mRNA density an

31 Luteinizing hormone (LH) induces maturational processes

32 The pulsatile release of luteinizing hormone (LH) is critical for mammalian ferti

33 Synthesis of luteinizing hormone (LH) is tightly controlled by a comp

34 c mouse strain that has chronically elevated luteinizing hormone (LH) levels (LH-CTP).

35 along with minimal repression of circulating luteinizing hormone (LH) levels and no change in the lip

36 The mean luteinizing hormone (LH) levels in ovariectomized rats w

37 Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels were measured in a subse

38 etion of GnRH is also reduced as basal serum luteinizing hormone (LH) levels were significantly lower

39 he fabrication of a nanosensor for detecting luteinizing hormone (LH) of sheep using a gold nanoparti

40 To determine whether the action of luteinizing hormone (LH) on the mouse ovarian follicle c

41 Luteinizing hormone (LH) pulsatility, body weight, ovari

42 Adult obesity is associated with blunted luteinizing hormone (LH) pulse amplitude that is partial

43 fertility, is associated with an increase in luteinizing hormone (LH) pulse frequency, implicating ab

44 from adults with previous reports of in vivo luteinizing hormone (LH) pulse frequency.

45 r cells in that they were 3betaHSD-negative, luteinizing hormone (LH) receptor (LHR)-negative, and pl

46 Recent studies suggest that luteinizing hormone (LH) receptor activation leads to tr

47 licular development, including expression of luteinizing hormone (LH) receptor by the granulosa cells

48 , an intracellular messenger formed when the luteinizing hormone (LH) receptor is activated.

49 l mechanisms play a major role in regulating luteinizing hormone (LH) receptor mRNA expression in the

50 Luteinizing hormone (LH) receptor mRNA is post-transcrip

51 eral motions of individual FLAG-tagged human luteinizing hormone (LH) receptors expressed on CHO cell

52 ave examined their ability to stimulate GnRH/luteinizing hormone (LH) release after peripheral or cen

53 atography was identified as OIF by eliciting luteinizing hormone (LH) release and ovulation in llamas

54 r the female-typical cyclic surge pattern of luteinizing hormone (LH) release.

55 provides the drive necessary for tonic GnRH/luteinizing hormone (LH) release.

56 acy and duration of action) of inhibition of luteinizing hormone (LH) release.

57 easing hormone (GnRH) neurons and subsequent luteinizing hormone (LH) release.

58 there is no information on the regulation of luteinizing hormone (LH) secretion by NKB or its recepto

59 positive and negative feedback control over luteinizing hormone (LH) secretion during the ovulatory

60 Locomotor activity and luteinizing hormone (LH) secretion in golden hamsters sh

61 istration of senktide (NK3R agonist) induced luteinizing hormone (LH) secretion in prepubertal and pe

62 on of these neurons would generate pulsatile luteinizing hormone (LH) secretion in vivo.

63 s characterized by the pattern of endogenous luteinizing hormone (LH) secretion on the basis of frequ

64 Changes in luteinizing hormone (LH) secretion that are observed in

65 (GnRH) neurons, which in turn supports basal luteinizing hormone (LH) secretion.

66 s of activation required to evoke a pulse of luteinizing hormone (LH) secretion.

67 g and follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion.

68 Luteinizing hormone (LH) stimulates steroidogenesis larg

69 Although mammalian oocytes ovulated after luteinizing hormone (LH) stimulation can be fertilized a

70 riggers germinal vesicle breakdown after the luteinizing hormone (LH) surge and reentry into the meio

71 have demonstrated that IL-1beta inhibits the luteinizing hormone (LH) surge during the afternoon of p

72 e in the generation of the preovulatory GnRH/luteinizing hormone (LH) surge in the female rodent.

73 linked to the induction of the preovulatory luteinizing hormone (LH) surge in the rat.

74 ntained in prophase meiotic arrest until the luteinizing hormone (LH) surge induces reentry into the

75 ut not males, to display an estrogen-induced luteinizing hormone (LH) surge is consistent with the hi

76 provides for the timing of the preovulatory luteinizing hormone (LH) surge necessary for ovulation i

77 irregular estrous cycles, lack a coordinated luteinizing hormone (LH) surge on the day of proestrus,

78 to escalating levels of estrogen, express a luteinizing hormone (LH) surge that is prompted by a sur

79 GnRH) surge is a prerequisite signal for the luteinizing hormone (LH) surge that triggers ovulation.

80 The midcycle luteinizing hormone (LH) surge triggers several tightly

81 the DM, up to the stage of the preovulatory luteinizing hormone (LH) surge, is impaired.

82 induction of maturation by the preovulatory luteinizing hormone (LH) surge.

83 event underlying generation of the ovulatory luteinizing hormone (LH) surge.

84 tion is induced by the preovulatory surge of luteinizing hormone (LH) that acts on the ovary and trig

85 fully grown follicles, prior to the surge of luteinizing hormone (LH) that triggers meiotic resumptio

86 at clearance rates for glycoproteins such as luteinizing hormone (LH) that undergo regulated release

87 Serum luteinizing hormone (LH) was likewise suppressed within

88 n-deficient mice exhibit increased levels of luteinizing hormone (LH), a pituitary hormone that regul

89 d concentrations of estradiol, progesterone, luteinizing hormone (LH), and follicle-stimulating hormo

90 mones follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and that ovarian steroids exer

91 pin's follicle-stimulating hormone (FSH) and luteinizing hormone (LH), both of which are heterodimers

92 In response to luteinizing hormone (LH), cGMP in the granulosa cells de

93 BG), dehydroepiandrosterone sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (

94 The gonadotropins, luteinizing hormone (LH), follicle-stimulating hormone (

95 Estradiol, estrone, testosterone, luteinizing hormone (LH), follicle-stimulating hormone (

96 Luteinizing hormone (LH), produced in the anterior lobe

97 pins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), under the control of pulsatile

98 ine, beta-endorphin, and enkephalin) inhibit luteinizing hormone (LH), vasopressin (VP), and oxytocin

99 In response to luteinizing hormone (LH), which binds to receptors on th

100 Dendrimer 3 showed similar luteinizing hormone (LH)-release activity to triptorelin

101 t measured urinary estrone-3-glucuronide and luteinizing hormone (LH).

102 tes under the pulsatile control of pituitary luteinizing hormone (LH).

103 in calcium oscillations and the secretion of luteinizing hormone (LH).

104 or Ink4c and Ink4d produces normal levels of luteinizing hormone (LH).

105 tory follicles resume meiosis in response to luteinizing hormone (LH).

106 ensatory elevation in levels of gonadotropin luteinizing hormone (LH).

107 ins, follicle-stimulating hormone (FSH), and luteinizing hormone (LH).

108 se hamster ovary cells expressing either the luteinizing hormone (LH)/chorionic gonadotropin (CG) or

109 ose demonstrating the presence of functional luteinizing hormone (LH)/hCG receptors in human breast c

110 to the pituitary and the resulting surge of luteinizing hormone (LH); however, the neural circuits t

111 r GalNAc to N-linked oligosaccharides on the luteinizing hormone alpha subunit and CA6 but not to tho

112 We measured follicle-stimulating hormone and luteinizing hormone and added information on menstrual p

113 oproteins including the glycoprotein hormone luteinizing hormone and carbonic anhydrase-6 (CA6).

114 A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear

115 yp2j5 (-/-) mice, but their plasma levels of luteinizing hormone and follicle stimulating hormone wer

116 The pituitary glycoprotein hormones, luteinizing hormone and follicle-stimulating hormone (FS

117 d equally well to the stimulatory actions of luteinizing hormone and follicle-stimulating hormone and

118 ce also have decreased circulating levels of luteinizing hormone and follicle-stimulating hormone but

119 Pituitary (luteinizing hormone and follicle-stimulating hormone) an

120 pulsatile release of gonadotropin hormones (luteinizing hormone and follicle-stimulating hormone) fr

121 gent induced high levels of the gonadotropin luteinizing hormone and increased the serum concentratio

122 e time course or the plasma concentration of luteinizing hormone and its physiological effects on the

123 -releasing hormone (GnRH) induces a surge of luteinizing hormone and ovulation in a variety of specie

124 Blood luteinizing hormone and prolactin (as a positive control

125 r that is efficacious for the suppression of luteinizing hormone and testosterone in primates.

126 axis and, thus, normalizes hormone levels of luteinizing hormone and testosterone.

127 restores gonadotrophin secretion, as well as luteinizing hormone and thyroid-stimulating hormone puls

128 nadotropins follicle-stimulating hormone and luteinizing hormone are heterodimeric glycoproteins expr

129 estradiol, follicle-stimulating hormone, and luteinizing hormone around the woman's own mean levels w

130 e required for gonadotrope specification and luteinizing hormone beta (LH beta) gene expression.

131 hether MIP-2A can transcriptionally regulate luteinizing hormone beta (LHbeta), a pituitary-specific

132 riptional activation of both the FSHbeta and luteinizing hormone beta subunit (LHbeta) gene promoters

133 arche by regulating the transcription of the luteinizing hormone beta subunit.

134 utant mouse, whereas proopiomelanocortin and luteinizing hormone beta-subunit expression were normal

135 The luteinizing hormone chorionic gonadotropin receptor (LHC

136 ycle arrested at prophase of meiosis I until luteinizing hormone from the pituitary acts on the folli

137 onding with an increase in expression of the luteinizing hormone gene, Lhb We demonstrate that poorly

138 adrenocorticotropic hormone, prolactin, and luteinizing hormone hyperplasia.

139 Oral administration of 10b suppressed luteinizing hormone in castrated macaques.

140 es the interictal and postictal secretion of luteinizing hormone in mesial temporal lobe epilepsy.

141 ony between follicle-stimulating hormone and luteinizing hormone in the luteal phase.

142 hCGbeta evolved from the beta subunit of luteinizing hormone in two phases.

143 one administration results in suppression of luteinizing hormone in wild-type male mice, but paradoxi

144 arcuate nucleus, and a reduced compensatory luteinizing hormone increase compared with control anima

145 er (13.4+/-3.2 nmol per liter, P<0.001), the luteinizing hormone level increased from 2.7+/-2.0 to 8.

146 one, follicle-stimulating hormone level, and luteinizing hormone level were measured and testicular h

147 had higher follicle-stimulating hormone and luteinizing hormone levels and lower estradiol levels at

148 , E1, E1S, follicle-stimulating hormone, and luteinizing hormone levels in all patients and the propo

149 ale mice, but paradoxically stimulates serum luteinizing hormone levels in GPRC6A(-/-) null mice.

150 estrous cycles and elevated testosterone and luteinizing hormone levels, suggesting altered hypothala

151 strongly associates with PCOS diagnosis and luteinizing hormone levels.

152 varies lacking corpora lutea and increase in luteinizing hormone levels.

153 the fasting-associated decrease in overnight luteinizing hormone pulse frequency but had no effect on

154 onic epilepsy was associated with changes in luteinizing hormone pulse frequency, amplitude, and mass

155 high free testosterone, and fewer numbers of luteinizing hormone pulses, but not polycystic-appearing

156 creases in testosterone and the testosterone/luteinizing hormone ratio were detected in men watching

157 t study investigated regulation of the human luteinizing hormone receptor (hLHR) gene by histone deac

158 The luteinizing hormone receptor (LHR) and beta2-adrenergic

159 n hormones to their cognate human receptors (luteinizing hormone receptor (LHR) and thyroid-stimulati

160 n A (TSA), induces derepression of the human luteinizing hormone receptor (LHR) gene by de-recruitmen

161 Transcription of luteinizing hormone receptor (LHR) gene is activated by

162 ously demonstrated that transcription of the luteinizing hormone receptor (LHR) gene is subject to re

163 We have demonstrated that silencing of luteinizing hormone receptor (LHR) gene transcription is

164 the past decade, however, the expression of luteinizing hormone receptor (LHR) has also been reporte

165 Our previous studies have identified a luteinizing hormone receptor (LHR) mRNA-binding protein

166 utant can inhibit signaling to G(s) from the luteinizing hormone receptor by 97% and from the calcito

167 Luteinizing hormone receptor is a G protein-coupled rece

168 s in the HinRs and the interhelical loops of luteinizing hormone receptor/follicle stimulating hormon

169 erize with its closely related receptor, the luteinizing hormone receptor; this association may have

170 PD-PALM of two functionally defined mutant luteinizing hormone receptors (LHRs), a ligand-binding d

171 as well as human chorionic gonadotropin and luteinizing hormone receptors on male breast tissue, may

172 Increased luteinizing hormone relative to follicle-stimulating hor

173 2) priming completely blocks hormone-induced luteinizing hormone release and partially inhibits hormo

174 series induced a much prolonged increase of luteinizing hormone release compared to KP10 and increas

175 , and screened for duration of inhibition of luteinizing hormone release in a castrated male rat assa

176 Inhibition of luteinizing hormone release over time was measured in th

177 ive degradation in the orderliness of serial luteinizing hormone release.

178 Luteinizing hormone releasing hormone (LHRH) gene transc

179 n of prostaglandin E2, which then stimulates luteinizing hormone releasing hormone (LHRH) neurons to

180 dy single-chain variable fragment (scFv) and luteinizing hormone releasing hormone (LHRH) peptide, re

181 Cytotoxic analogue of luteinizing hormone releasing hormone (LHRH), AN-207, bi

182 Irradiation of luteinizing hormone releasing hormone (LHRH), growth hor

183 n releasing hormone-1 [GnRH-1, also known as luteinizing hormone releasing hormone (LHRH)] neurons ca

184 Bilateral orchiectomy or luteinizing hormone releasing hormone agonists are the r

185 Luteinizing hormone releasing hormone analog (LHRHa, des

186 ne and metabolic variables were measured and luteinizing hormone sampled over 8 hours on days 2 to 5

187 for estradiol-mediated suppression of tonic luteinizing hormone secretion (an indirect measure of Gn

188 crucial role in the regulation of pituitary luteinizing hormone secretion and reproduction.

189 Pulsatile luteinizing hormone secretion and spermatogenesis were d

190 We characterized luteinizing hormone secretion in patients with mesial te

191 Deconvolution analysis defined luteinizing hormone secretion in terms of interpulse int

192 rs in GnIH-ir nuclei, and GnIH inhibition of luteinizing hormone secretion indicate the discovery of

193 stent with a role in regulating preovulatory luteinizing hormone secretion, rostral projections from

194 cute seizures induced timing irregularity in luteinizing hormone secretion, whereas chronic epilepsy

195 ted a robust GnRH discharge, as reflected by luteinizing hormone secretion, which was abolished by pr

196 In vivo GnIH administration rapidly inhibits luteinizing hormone secretion.

197 lels between MSP signaling in C. elegans and luteinizing hormone signaling in mammals.

198 g, n = 24; 12.8 nmol/kg, n = 24) to induce a luteinizing hormone surge and egg maturation.

199 otein increased >10-fold after the ovulatory luteinizing hormone surge in wild-type but not PRKO mice

200 t in the ovary for extended periods before a luteinizing hormone surge induces entry into the first m

201 eleasing hormone (GnRH) release triggers the luteinizing hormone surge that induces ovulation.

202 losa cells of periovulatory follicles by the luteinizing hormone surge through a progesterone recepto

203 han during the luteal phase (6-10 days after luteinizing hormone surge).

204 ein alters the amplitude of the preovulatory luteinizing hormone surge, likely by perturbing GnRH rel

205 n several hours after the ovulation-inducing luteinizing hormone surge, whereas they undergo differen

206 kisspeptin is involved in generation of the luteinizing hormone surge, which is required for ovulati

207 d by the puberty-triggering and preovulatory luteinizing hormone surge-mediating peptide, kisspeptin.

208 expected time of the proestrous preovulatory luteinizing hormone surge.

209 d for regulation of a full preovulatory-like luteinizing hormone surge.

210 n brain slices from a model exhibiting daily luteinizing hormone surges.

211 Luteinizing hormone then acts on receptors in outer gran

212 nts with abnormal levels of testosterone and luteinizing hormone was less pronounced-57% and 21%, res

213 estradiol, total and free testosterone, and luteinizing hormone were higher by 5.26% (95% CI: 1.27%,

214 We used transgenic mice that overexpress luteinizing hormone with subsequent ovarian hyperstimula

215 Serum levels of LH (luteinizing hormone) and testosterone were measured by r

216 ed puberty associated with low or apulsatile luteinizing hormone) in both humans and in the mouse mod

217 rsting activity associated with the GnRH/LH (luteinizing hormone) surge.

218 ic antigen, thyroid stimulating hormone, and luteinizing hormone) were printed in an array format ont

219 ailure (low/normal testosterone and elevated luteinizing hormone).

220 Ratios of follicle stimulating hormone to luteinizing hormone, a sexual maturity indicator, in all

221 sisting of an alpha subunit, also present in luteinizing hormone, and a unique beta subunit, which is

222 ormones: human chorionic gonadotropin, human luteinizing hormone, and follicle stimulating hormone by

223 Estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone we

224 erum levels of CRP, estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone we

225 droepiandrosterone (DHEAS), androstenedione, luteinizing hormone, and follicle-stimulating hormone.

226 d levels of follicle-stimulating hormone and luteinizing hormone, and increased variability of estrad

227 owth factor 1, follicle-stimulating hormone, luteinizing hormone, and testosterone levels).

228 for zonulin and antibodies against GnRH and luteinizing hormone, and their receptors.

229 l follicles, independently of an increase in luteinizing hormone, and this phenotype can be reversed

230 energy, vitamin E intake, physical activity, luteinizing hormone, follicle-stimulating hormone, and p

231 nophore-induced acrosome reaction as well as luteinizing hormone, follicle-stimulating hormone, and t

232 Estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, sex h

233 t explained by any deficits in testosterone, luteinizing hormone, or follicle-stimulating hormone con

234 ens, disrupted reproductive cycles, and high luteinizing hormone, the latter reflecting increased gon

235 tes pituitary synthesis of a large amount of luteinizing hormone, which is required for ovulation.

236 Tight regulation of luteinizing hormone-beta subunit (LHbeta) expression is

237 e generated by breeding MMTV-Neu mice with a luteinizing hormone-overexpressing mouse model of ovaria

238 /23), mainly in follicle-stimulating hormone/luteinizing hormone-producing (38%) and null cell (57%)

239 ombesin (AN-215), somatostatin (AN-238), and luteinizing hormone-releasing hormone (AN-207) consisted

240 Treatment with antagonists of luteinizing hormone-releasing hormone (LH-RH) leads to d

241 The effects of depot formulations of the luteinizing hormone-releasing hormone (LHRH) agonist Dec

242 Treatment with a luteinizing hormone-releasing hormone (LHRH) agonist inc

243 orticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D

244 Ovarian suppression with luteinizing hormone-releasing hormone (LHRH) agonists is

245 the recent developments on BPH therapy with luteinizing hormone-releasing hormone (LHRH) antagonist

246 tance and (5) a modified synthetic analog of luteinizing hormone-releasing hormone (LHRH) as a target

247 Luteinizing hormone-releasing hormone (LHRH) neurons mig

248 Functionalized with luteinizing hormone-releasing hormone (LHRH) peptide via

249 Importantly, SSA induced by luteinizing hormone-releasing hormone (LHRH) receptor an

250 estigate the mechanism by which Mn2+ induces luteinizing hormone-releasing hormone (LHRH) secretion f

251 s by which the neuroendocrine brain controls luteinizing hormone-releasing hormone (LHRH) secretion.

252 Luteinizing hormone-releasing hormone (LHRH) was used as

253 large doses of Cetrorelix, an antagonist of luteinizing hormone-releasing hormone (LHRH), reduces le

254 naling pathway that prompts the secretion of luteinizing hormone-releasing hormone (LHRH), the neurop

255 ne (LH) surge that is prompted by a surge in luteinizing hormone-releasing hormone (LHRH).

256 othalamic neurons secreting the neuropeptide luteinizing hormone-releasing hormone (LHRH).

257 ng afferent pathways to neurons synthesizing luteinizing hormone-releasing hormone (LHRH, also known

258 coexpressed in neurons containing mammalian luteinizing hormone-releasing hormone (m-LHRH).

259 itive tumors also received letrozole (plus a luteinizing hormone-releasing hormone [LHRH] agonist if

260 diation plus immediate androgen suppression (luteinizing hormone-releasing hormone [LHRH] agonist), w

261 steroid ablation using leuprolide acetate, a luteinizing hormone-releasing hormone agonist (LHRHa), i

262 Luteinizing hormone-releasing hormone agonist (LHRHa; le

263 AST, which was defined as 6 months of both a luteinizing hormone-releasing hormone agonist and an ant

264 ts receiving combined androgen blockade with luteinizing hormone-releasing hormone agonist and bicalu

265 les, followed by total androgen suppression (luteinizing hormone-releasing hormone agonist plus bical

266 tients were randomized soon after initiating luteinizing hormone-releasing hormone agonist with antia

267 n deprivation (AD) to cixutumumab added to a luteinizing hormone-releasing hormone agonist with bical

268 S; two injections of every-3-months depot of luteinizing hormone-releasing hormone agonist) to primar

269 Patients were randomly assigned 2:1 to a luteinizing hormone-releasing hormone agonist, bicalutam

270 Bilateral orchiectomy or luteinizing hormone-releasing hormone agonists are recom

271 ; and three, when chemical suppression using luteinizing hormone-releasing hormone agonists is the ch

272 of 5 ng per milliliter or higher received a luteinizing hormone-releasing hormone analogue and an an

273 Whether the administration of luteinizing hormone-releasing hormone analogues (LHRHa)

274 s monotherapy or with adjuvant castration or luteinizing hormone-releasing hormone superagonists to b

275 For luteinizing hormone-releasing hormone, all but two expec

276 k suggests that cytotoxic peptide analogs of luteinizing hormone-releasing hormone, somatostatin, and

277 hormone-secreting (GH-secreting) GH3 cells, luteinizing hormone-secreting (LH-secreting) LbetaT2 cel

278 and lower levels of endogenous estradiol and luteinizing hormone.

279 gesterone, follicle-stimulating hormone, and luteinizing hormone.

280 iosynthesis before the preovulatory surge of luteinizing hormone.

281 d all had abnormal secretion of GnRH-induced luteinizing hormone.

282 in a significant decrease in serum levels of luteinizing hormone.

283 ted by the downstream pulsatile secretion of luteinizing hormone.

284 e, thereby inhibiting the proestrus surge in luteinizing hormone.

285 2 binding to the active but unphosphorylated luteinizing hormone/choriogonadotropin receptor (LH/CG R

286 hat agonist-dependent desensitization of the luteinizing hormone/choriogonadotropin receptor (LH/CG R

287 ine 3 (Org 41841), a partial agonist for the luteinizing hormone/choriogonadotropin receptor (LHCGR)

288 Signaling by the luteinizing hormone/choriogonadotropin receptor (LHR) is

289 We tested here, using hypogonadal luteinizing hormone/choriongonadotropin receptor (LHCGR)

290 identified previously as an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHC

291 mical analysis colocalized expression of the luteinizing hormone/chorionic gonadotropin receptor, PRO

292 Activation of the luteinizing hormone/human chorionic gonadotropin (LH/hCG

293 third transmembrane alpha-helix (TM3) of the luteinizing hormone/human chorionic gonadotropin recepto

294 The luteinizing hormone/human chorionic gonadotropin recepto

295 ollicular differentiation markers, including luteinizing-hormone receptor (LHR), inhibin-alpha, micro

296 ted with high follicle-stimulating (FSH) and luteinizing (LH) hormone levels.

297 5a prevents follicle-stimulating hormone and luteinizing protein from up-regulating the CTNNB1 and CR

298 The mutant stromal cells consist of a luteinized theca cell lineage at various differentiation

299 inducing cells, the identification of mutant luteinized theca cells may add crucial evidence in under

300 ether, our results suggest that GT198 mutant luteinized theca cells overexpressing CYP17 are common i